Osimertinib as a Potential Targeted Therapy for Non-Small Cell Lung Carcinoma (NSCLC) Patients with EGFR Exon 20 T790M

BACKGROUND: Emergence of drug resistance due to epidermal growth factor receptor (EGFR) Exon 20 T790M poses a challenge in the effective management of non-small cell lung carcinoma (NSCLC). Significant breakthrough in the management of NSCLC with a specific genetic alteration causes substantial cond...

Full description

Bibliographic Details

Published in:	Indonesian Biomedical Journal
Main Authors:	Nur Zam Zam, Harun Iskandar, Nur Ahmad Tabri, Arif Santoso, Nurjannah Lihawa, Harry Akza Putrawan, Ferry Sandra
Format:	Article
Language:	English
Published:	Secretariat of The Indonesian Biomedical Journal 2023-10-01
Online Access:	https://inabj.org/index.php/ibj/article/view/2431